{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:48:07Z","timestamp":1780422487782,"version":"3.54.1"},"reference-count":23,"publisher":"BMJ","issue":"3","funder":[{"name":"Stanford Impact Labs","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2023,2,27]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess interest in clinician-administered advance provision of abortion pills among potential users in the USA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using social media advertisements, we recruited people living in the USA who were aged 18\u201345\u2009years and assigned female at birth, who were not pregnant or planning pregnancy, for an online survey on reproductive health experiences and attitudes. We explored interest in advance provision of abortion pills, participant characteristics, including demographics and pregnancy history, contraceptive use, abortion knowledge and comfort, and healthcare system distrust. We used descriptive statistics to assess interest in advance provision, and ordinal regression modelling to evaluate differences in interest controlling for age, pregnancy history, contraceptive use, familiarity and comfort with medication abortion, and healthcare system distrust, reporting adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From January-February 2022, we recruited 634 diverse respondents from 48 states, among whom 65% were interested, 12% neutral, and 23% disinterested in advance provision. There were no differences among interest groups by US region, race\/ethnicity, or income. In the model, variables associated with interest included being aged 18\u201324 years (aOR 1.9, 95% CI 1.0 to 3.4) versus 35\u201345 years, using a tier 1 (permanent or long-acting reversible) or tier 2 (short-acting hormonal) contraceptive method (aOR 2.3, 95% CI 1.2 to 4.1, and aOR 2.2, 95% CI 1.2 to 3.9, respectively) versus no contraception, being familiar or comfortable with the medication abortion process (aOR 4.2, 95% CI 2.8 to 6.2, and aOR 17.1, 95% CI 10.0 to 29.0, respectively), and having high healthcare system distrust (aOR 2.2, 95% CI 1.0 to 4.4) versus low distrust.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>As abortion access becomes more constrained, strategies are needed to ensure timely access. Advance provision is of interest to the majority of those surveyed and warrants further policy and logistical exploration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjsrh-2022-201775","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T13:22:17Z","timestamp":1678195337000},"page":"183-191","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Interest in advance provision of abortion pills: a national survey of potential users in the USA"],"prefix":"10.1136","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-9814","authenticated-orcid":false,"given":"Klaira","family":"Lerma","sequence":"first","affiliation":[{"name":"Population Research Center, The University of Texas at Austin, Austin, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Blumenthal","sequence":"additional","affiliation":[{"name":"Division of Family Planning Services and Research, Department of Obstetrics and Gynecology, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"2025090511491382000_49.3.183.1","unstructured":"Center for Reproductive Rights . After Roe fell: abortion laws by state. 2022. Available: https:\/\/reproductiverights.org\/maps\/abortion-laws-by-state\/"},{"key":"2025090511491382000_49.3.183.2","unstructured":"Kirstein M , Dreweke J , Jones RK , et al . 100 days post-Roe: at least 66 clinics across 15 US states have stopped offering abortion care. Guttmacher Institute, 2022. Available: www.guttmacher.org\/2022\/10\/100-days-post-roe-least-66-clinics-across-15-us-states-have-stopped-offering-abortion-care"},{"key":"2025090511491382000_49.3.183.3","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.2022.20424","article-title":"Estimated travel time and spatial access to abortion facilities in the US before and after the Dobbs V Jackson women\u2019s health decision","volume":"328","author":"Rader","year":"2022","journal-title":"JAMA"},{"key":"2025090511491382000_49.3.183.4","article-title":"Cross-state travel for abortion care","volume":"10","author":"Bearak","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2025090511491382000_49.3.183.5","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1001\/jama.2022.20423","article-title":"Association of Texas\u2019 2021 ban on abortion in early pregnancy with the number of facility-based abortions in Texas and surrounding states","volume":"328","author":"White","year":"2022","journal-title":"JAMA"},{"key":"2025090511491382000_49.3.183.6","unstructured":"Meyers C , Bennett L , Vale F , et al . Abortion access dashboard. 2022. Available: https:\/\/abortionaccessdashboard.org\/"},{"key":"2025090511491382000_49.3.183.7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.contraception.2018.10.007","article-title":"Support for and interest in alternative models of medication abortion provision among a national probability sample of U.S. women","volume":"99","author":"Biggs","year":"2019","journal-title":"Contraception"},{"key":"2025090511491382000_49.3.183.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2021-201321"},{"key":"2025090511491382000_49.3.183.9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7004a1"},{"key":"2025090511491382000_49.3.183.10","unstructured":"Jones RK , Nash E , Cross L , et al . Medication abortion now accounts for more than half of all US abortions. Guttmacher Institute, 2022. Available: https:\/\/www.guttmacher.org\/article\/2022\/02\/medication-abortion-now-accounts-more-half-all-us-abortions"},{"key":"2025090511491382000_49.3.183.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0575-3"},{"key":"2025090511491382000_49.3.183.12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.contraception.2019.05.013","article-title":"TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States","volume":"100","author":"Raymond","year":"2019","journal-title":"Contraception"},{"key":"2025090511491382000_49.3.183.13","unstructured":"Department of Health and Human Services . U.S. federal poverty guidelines used to determine financial eligibility for certain federal programs. 2021. Available: https:\/\/aspe.hhs.gov\/topics\/poverty-economic-mobility\/poverty-guidelines\/prior-hhs-poverty-guidelines-federal-register-references\/2021-poverty-guidelines#threshholds"},{"key":"2025090511491382000_49.3.183.14","unstructured":"Donovan MK . Self-managed medication abortion: expanding the available options for U.S. abortion care. Guttmacher Institute, 2018. Available: https:\/\/www.guttmacher.org\/gpr\/2018\/10\/self-managed-medication-abortion-expanding-available-options-us-abortion-care"},{"key":"2025090511491382000_49.3.183.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.15679"},{"key":"2025090511491382000_49.3.183.16","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.amepre.2015.04.001","article-title":"Confidentiality in family planning services for young people: a systematic review","volume":"49","author":"Brittain","year":"2015","journal-title":"Am J Prev Med"},{"key":"2025090511491382000_49.3.183.17","unstructured":"Lantos H , Pliskin E , Wildsmith E , et al . State-level abortion restrictions will negatively impact teens and children. Child Trends, 2022. Available: https:\/\/www.childtrends.org\/blog\/state-level-abortion-restrictions-will-negatively-impact-teens-and-children"},{"key":"2025090511491382000_49.3.183.18","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/jwh.2016.5810","article-title":"Health literacy and women\u2019s reproductive health: a systematic review","volume":"25","author":"Kilfoyle","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"2025090511491382000_49.3.183.19","first-page":"44","article-title":"This tangled web of reproductive morbidity risk: abortion stigma, safety & legality","volume":"1","author":"Ostrach","year":"2016","journal-title":"Frontiers in Womens\u2019 Health"},{"key":"2025090511491382000_49.3.183.20","unstructured":"National Academies of Sciences E, and Medicine . The safety and quality of abortion care in the United States. 2018."},{"key":"2025090511491382000_49.3.183.21","article-title":"Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: a population based study","volume":"10","author":"Aiken","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2025090511491382000_49.3.183.22","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMp2209737","article-title":"Abortion access as a racial justice issue","volume":"387","author":"Kozhimannil","year":"2022","journal-title":"N Engl J Med"},{"key":"2025090511491382000_49.3.183.23","unstructured":"Pew Research Center . Americans\u2019 views on whether, and in what circumstances, abortion should be legal. 2022. Available: www.pewresearch.org\/religion\/2022\/05\/06\/americans-views-on-whether-and-in-what-circumstances-abortion-should-be-legal\/"}],"container-title":["BMJ Sexual &amp; Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2022-201775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:03:11Z","timestamp":1757098991000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2022-201775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,7,12]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/bmjsrh-2022-201775"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2022-201775","relation":{},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"value":"2515-1991","type":"print"},{"value":"2515-2009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]}}}